Investigation of postjunctional α1‐ and α2‐adrenoceptor subtypes in vas deferens from wild‐type and α2A/D‐adrenoceptor knockout mice
- 1 March 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (6) , 1069-1076
- https://doi.org/10.1038/sj.bjp.0705137
Abstract
1. The subtypes of alpha(1)- and alpha(2)-adrenoceptor mediating contractions of vas deferens have been examined in wild-type and alpha(2A/D)-adrenoceptor knockout mice. 2. Maximum contractions to noradrenaline but not phenylephrine were significantly greater in vas from wild-type. The alpha(1A)-adrenoceptor antagonist RS100329 (5-methyl-3-[3-[4-[2-(2,2,2,-trifluoroethoxy)phenyl]-1-piperazinyl]propyl]-2,4-(1H)-pyrimidinedione) (10 nM) significantly shifted the potency of noradrenaline. The alpha(2D)-adrenoceptor antagonist BRL 44408 (2-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole) significantly reduced the maximum contraction to noradrenaline in wild-type but not in knockout. 3. Following prazosin (0.1 micro M), a component of the contraction to noradrenaline in wild-type but not in knockout was sensitive to the alpha(2)-adrenoceptor antagonist yohimbine. 4. Nifedipine (10 micro M) or suramin (100 micro M) reduced the contraction to 10 Hz stimulation for 4 s to an early peak and small maintained response. The peak was abolished by the alpha(1)-adrenoceptor antagonist prazosin. 5. RS100329 or prazosin inhibited 10 Hz stimulation evoked contractions with a U-shaped concentration-response curve: inhibiting responses up to 0.1 micro M, with a reversal of inhibition above this concentration. In the presence of suramin or nifedipine, the reversal of inhibition by high concentrations of prazosin was reduced. 6. The alpha(1D)-adrenoceptor selective antagonist BMY7378 (8-[2-(4-(2- methoxyphenyl)piperazin-1-yl)ethyl]-8-azaspiro[4,5]decane-7,9-dione) produced inhibition of 10 Hz evoked contractions only in high concentrations. 7. In conclusion, contractions to nerve stimulation in mouse vas deferens involve largely alpha(1A)-adrenoceptors and purinoceptors. alpha(1)-Adrenoceptor antagonists in high concentrations increase the purinergic response presumably by blocking prejunctional alpha(2)-adrenoceptor-mediated inhibition. In the presence of nifedipine, responses are predominantly alpha(1)-adrenoceptor mediated. Contractions to exogenous noradrenaline involved both alpha(1A)- and alpha(2A/D)-adrenoceptors in wild-type mice.Keywords
This publication has 33 references indexed in Scilit:
- Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and α2A/D-adrenoceptor knockout miceEuropean Journal of Pharmacology, 2001
- Investigation of the subtypes of α1‐adrenoceptor mediating contractions of rat vas deferensBritish Journal of Pharmacology, 1999
- In vitroα1‐adrenoceptor pharmacology of Ro 70–0004 and RS‐100329, novel α1A‐adrenoceptor selective antagonistsBritish Journal of Pharmacology, 1999
- α1L‐Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of manBritish Journal of Pharmacology, 1998
- α1-Adrenoceptor-induced contractility in rat aorta is mediated by the α1D subtypeEuropean Journal of Pharmacology, 1996
- BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptorsEuropean Journal of Pharmacology, 1995
- Molecular characterization of α1- and α2-adrenoceptorsTrends in Pharmacological Sciences, 1991
- Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- α1Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscleNature, 1987
- Further examination of the inhibitory actions of α1-adrenoceptor agonists in rat vas deferensEuropean Journal of Pharmacology, 1985